1. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Issue 10191 (29th June 2019) Authors: Earl, Helena M; Hiller, Louise; Vallier, Anne-Laure; Loi, Shrushma; McAdam, Karen; Hughes-Davies, Luke; Harnett, Adrian N; Ah-See, Mei-Lin; Simcock, Richard; Rea, Daniel; Raj, Sanjay; Woodings, Pamela; Harries, Mark; Howe, Donna; Raynes, Kerry; Higgins, Helen B; Wilcox, Maggie; Plummer, Chris; Ma... Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Has the Oncotype DX Breast Cancer Assay influenced the use of chemotherapy? – The Warwick experience. Issue 5 (May 2017) Authors: Khan, Mashuk; Henderson, Laura; Walji, Nawaz; Hrouda, Denise; Harries, Simon; Clarke, Dayalan; Jones, Lucie Journal: European journal of surgical oncology Issue: Volume 43:Issue 5(2017:May) Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Has the Oncotype DX Breast Cancer Assay influenced the use of chemotherapy? – The Warwick experience. Issue 5 (May 2017) Authors: Khan, Mashuk; Henderson, Laura; Walji, Nawaz; Hrouda, Denise; Harries, Simon; Clarke, Dayalan; Jones, Lucie Journal: European journal of surgical oncology Issue: Volume 43:Issue 5(2017:May) Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Peri‐menopausal estrogen could prevent breast cancer; AGAINST. (6th April 2021) Authors: Choudhary, Yash; Walji, Nawaz Journal: BJOG Issue: Volume 128:Number 8(2021) Page Start: 1385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. Issue 5 (May 2020) Authors: King, Madeleine T; Link, Emma K; Whelan, Tim J; Olivotto, Ivo A; Kunkler, Ian; Westenberg, Antonia Helen; Gruber, Guenther; Schofield, Penny; Chua, Boon H; Chua, Boon H; Phillips, Claire; Bryant, Guy; Westenberg, Helen; Purohit, Om Pra-Kesh; Ahern, Verity; Graham, Peter; Akra, Mohamed; McArdle, O... Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗